Our research…

We are interested in emotional and physical health and how they impact each other.

Our science-backed programmes are being developed through research and biomedical testing.

In response to the Coronavirus pandemic, we have also turned our attention to COVID-19 diagnostics.

Our research…

We are interested in emotional and physical health and how they impact each other.

Our science-backed programmes are being developed through research and biomedical testing.
In response to the Coronavirus pandemic, we have also turned our attention to COVID-19 diagnostics.

Our current research into emotional health and behavioural endocrinology

We are studying the relationship between our hormones, moods, feelings and emotions – and how they affect our emotional health, as well as our behaviours.

Using biomedicine and psychological testing we can measure the effect of psychoeducation and other therapeutic practices to accurately predict what we can do to support our wellbeing.

Our research into Coronavirus and beyond

Human beings are complex organisms.
To get a full understanding of a body’s disease it can be necessary to do multiple tests.

This can very quickly become prohibitively expensive, which means that diseases can go undetected.
NISAD’s laboratory science arm – NISAD-MAP – is working to change this.

Through the use of MALDI-ToF mass spectrometry, our head of Biomedical Science, Professor Ray Iles, is leading the development of a new technology.

It will make it easier and cheaper to detect intractable human conditions (such as haemoglobinopathies) as well as world-wide pandemic threats from emerging viruses like COVID-19.

We are not going to settle for the status quo: we are pioneering the next advancement, not just in those places where resources are still relatively abundant – but for the benefit of everyone, everywhere.

Coronavirus testing

NISAD-MAP’s head of biomedical science is researching a much less expensive and much faster way of testing for the coronavirus using mass spectrometry.

This test will inform people whether they are infected with the virus and enable them to make informed decisions about their current physical health.

Testing for Coronavirus antibodies

Following on from this, NISAD is researching a much less expensive and much faster way of testing for Coronavirus antibodies using mass spectrometry. This test will inform people whether or not they have had COVID-19 and will include advice on the level of immunity they are likely to have based on the result of the test, thereby giving them greater agency to make informed decisions about their current physical health.

We are researching the development of a diagnostic technology that rapidly and cheaply detects ALL future epidemic and pandemic virus outbreaks.

Our attention is on the current pandemic and also on the future beyond COVID-19.

To focus solely on COVID-19 would be like putting a sticking plaster over a wound then waiting for it to fester and explode. We must look further into the future and create the means through which we can properly heal the wound of this pandemic as well as manage and contain future outbreaks.

The availability of rapid testing would mean we can isolate a virus and prevent transmission in our globally-connected society, thereby safe-guarding lives as well as the entire economic stability of all our countries around the world.

Insight, Stories & News